These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16203055)

  • 1. [Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)].
    Bouali F; Berrah A; Si Ahmed-Bouali D; Harrieche F; Benhalima M; Hamladji RM; Arrada M
    Rev Med Interne; 2005 Oct; 26(10):777-83. PubMed ID: 16203055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of systemic diseases and myelodysplastic syndromes. A retrospective study of 14 cases].
    Roy-Peaud F; Paccalin M; Le Moal G; Landron C; Juhel L; Roblot P; Becq-Giraudon B
    Presse Med; 2003 Mar; 32(12):538-43. PubMed ID: 12714920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap syndromes with sarcoidosis.
    James DG; Sharma OP
    Sarcoidosis; 1985 Sep; 2(2):116-21. PubMed ID: 3843140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study.
    Ramakrishna R; Chaudhuri K; Sturgess A; Manoharan A
    Q J Med; 1992 Jul; 83(303):547-54. PubMed ID: 1484932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplasias and systemic diseases. A non-fortuitous association].
    Berthier S; Magy N; Gil H; Schneider MB; Vuitton DA; Dupond JL
    Rev Med Interne; 2001 May; 22(5):428-32. PubMed ID: 11402513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diseases associated with dermatitis herpetiformis.
    Reunala T; Collin P
    Br J Dermatol; 1997 Mar; 136(3):315-8. PubMed ID: 9115907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
    Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
    Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
    Fain O; Braun T; Stirnemann J; Fenaux P
    Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The myelodysplastic syndrome and autoimmunity].
    Laursen SB; Nielsen MØ; Hasselbalch HC
    Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study.
    Lee SJ; Park JK; Lee EY; Joo SH; Jung KC; Lee EB; Song YW; Yoon SS
    Medicine (Baltimore); 2016 Mar; 95(13):e3091. PubMed ID: 27043672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Saif MW; Hopkins JL; Gore SD
    Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gougerot-Sjögren syndrome, connective tissue diseases and autoimmune pathology].
    Kaplan G; Vinceneux P; Bourgeois P; Kahn MF
    Rev Rhum Mal Osteoartic; 1977; 44(7-9):471-8. PubMed ID: 910105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic diseases in myelodysplastic syndromes].
    Hebbar M; Hebbar-Savéan K; Fenaux P
    Rev Med Interne; 1995; 16(12):897-904. PubMed ID: 8570952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular manifestations in systemic immune disorders].
    Karma A
    Duodecim; 1986; 102(18):1322-34. PubMed ID: 3769828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Collagen diseases complicated with myelodysplastic syndrome (MDS)--report of three cases].
    Takashima H; Eguchi K; Origuchi T; Yamasita I; Nakashima M; Ida H; Sakai M; Simada H; Kawabe Y; Nagataki S
    Ryumachi; 1994 Feb; 34(1):48-53. PubMed ID: 8146728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and survival analysis in primary myelodysplastic syndromes patients with immunological abnormalities].
    Li B; Xu ZF; Cui R; Chen YD; Su T; Zhang TJ; Fang LW; Zhang HL; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):527-31. PubMed ID: 22967411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of erythema nodosum and serositis associated with myelodysplastic syndrome.
    Choi JH; Ahn MJ; Park YW; Oh HS; Lee YY; Kim IS
    Korean J Intern Med; 2005 Jun; 20(2):177-9. PubMed ID: 16134776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between myelodysplastic syndromes and autoimmune disorders.
    Zhao S; Mao H; Wang H; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
    Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.